Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men

Journal of Internal Medicine

Volumn 256, Issue 5, 2004, Pages 413-420

  Wallenfeldt, Karin ^a,b   Fagerberg, B ^a,b   Wikstrand, J ^b,c   Hulthe, J ^b,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Atheroma; Atherosclerosis; LDL cholesterol; Ultrasonography

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; B SCAN; CAROTID ARTERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; INTIMA; LIPOPROTEIN BLOOD LEVEL; MALE; PLASMA; PRIORITY JOURNAL; PROGNOSIS; THICKNESS; TUNICA MEDIA; ULTRASOUND;

ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL, LDL; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 7244220166     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01402.x     Document Type: Article

References (29)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995; 92: 3893-7.
3. Yla-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989; 84: 1086-95.
4. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994; 14: 32-40.
5. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990; 10: 336-49.
6. Palinski W, Rosenfeld ME, Yla-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989; 86: 1372-6.
7. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 100-7.
8. Holvoet P, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 2000; 20: 698-702.
9. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487-94.
10. Holvoet P, Mertens A, Verhamme P et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844-8.
11. Toshima S, Hasegawa A, Kurabayashi M et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243-7.
12. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
13. Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994; 236: 567-73.
14. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997; 28: 1189-94.
15. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol 2002; 22: 1162-7.
16. Bokemark L, Wikstrand J, Wedel H, Fagerberg B. Intact insulin, insulin propeptides, and intima-media thickness in the carotid artery in 58-year-old clinical healthy men. The Atherosclerosis and Insulin Resistance study. Diabet Med 2002; 19: 144-51.
17. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997; 28: 2195-200.
18. Schmidt C, Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol 1999; 19: 45-55.
19. Wendelhag I, Wiklund O, Wikstrand J, Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia, Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993; 13: 1404-11.
20. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 1991; 11: 565-77.
21. Borner K, Klose S. Enzymatic determination of total cholesterol with the Greiner Selective Analyzer (GSA-II) (author's transl). J Clin Chem Clin Biochem 1977; 15: 121-30.
22. Wahlefeld A. Triglycerides: determination after enzymatic hydrolysis. In: Bermeyer H, ed. Methods of Enzymatic Analysis, 2nd edn. New York: Academic Press Inc., 1974: 18-31.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
24. Holvoet P, Donck J, Landeloos M et al. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996; 76: 663-9.
25. Tsimikas S, Bergmark C, Beyer RW et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003; 41; 360-70.
26. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103: 926-33.
27. Holvoet P, Collen D. Beta-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997; 17: 2376-82.
28. Holvoet P, Theilmeier G, Shivalkar B, Flameng W, Collen D. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998; 18: 415-22.
29. Sigurdardottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 2002; 252: 440-7.